CLAIM CARD
Telomere length emerges as a dualistic biomarker where elongation simultaneously lowers cardiovascular risk but elevates cancer susceptibility, with the magnitude of these effects critically modulated by genetic variants, measurement precision, and disease-specific contexts like pulmonary fibrosis.
Evidence grade: exploratory
Contradiction status: none
Publication: a333cf41-09e0-46b6-8b35-0a83469ca23b
Provenance: Derivation Web chain
Citation Support
source_1Telomere length and aging‐related outcomes in humans: A Mendelian randomization study in 261,000 older participantssource_2The Association of Telomere Length in Peripheral Blood Cells with Cancer Risk: A Systematic Review and Meta-analysis of Prospective Studiessource_3**Topic:** `telomere`source_4**Author:** Dom Lynchsource_5**ORCID:** _not configured_